What We Did
We conducted a comprehensive analysis that involved the identification of both patented and non-patented references detailing synthetic biomolecules designed to bind to cancer receptors for potential cancer treatment applications.
Moreover, we delved into an in-depth evaluation of the efficacy and potential side effects associated with these synthetic biomolecules, sourcing our information from clinical trial databases.
In addition, we explored the various modes of delivery for these biomolecules, including innovative approaches such as lipid nanoparticles and sustained-release formulations.